Skip to main content

Olaparib

ADVERTISEMENT
Identification
Molecular formula
C24H23N5O3
CAS number
763113-22-0
IUPAC name
11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
State
State

At room temperature, Olaparib is in a solid state. Its crystalline form allows it to be processed into a medicinal tablet or capsule.

Melting point (Celsius)
223.80
Melting point (Kelvin)
496.80
Boiling point (Celsius)
713.40
Boiling point (Kelvin)
986.60
General information
Molecular weight
434.47g/mol
Molar mass
434.4660g/mol
Density
1.4013g/cm3
Appearence

Olaparib appears as a white to off-white crystalline solid. It is practically insoluble in aqueous solutions, which is typical for many pharmaceutical compounds. When examined closely, the crystal structure can be appreciated, allowing for efficient formulation into various dosage forms.

Comment on solubility

Solubility of 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one

The solubility of C24H23N5O3, commonly referred to as 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one, can be quite significant in various solvents. Understanding its solubility is crucial for its practical applications and interactions in chemical processes. Here are some key points regarding its solubility:

  • Polar Solvents: This compound shows improved solubility in polar solvents such as dimethyl sulfoxide (DMSO) and methanol, which can facilitate its use in aqueous solutions.
  • Non-Polar Solvents: It is relatively less soluble in non-polar solvents like hexane and cyclohexane, typically due to the presence of polar functional groups.
  • pH Dependency: The solubility may also be influenced by pH levels, which can affect the ionization of the compound, thus altering its solubility profile in aqueous solutions.
  • Temperature Effects: An increase in temperature generally enhances solubility for many organic compounds, including this one, promoting greater molecular movement and interaction with solvent molecules.

In summary, the solubility characteristics of C24H23N5O3 play an essential role in its utility in different chemical environments, making it vital for researchers and scientists to consider these factors when employing this compound in various applications.

Interesting facts

Interesting Facts about 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one

This fascinating compound belongs to the benzodiazepine family, which is known primarily for its pharmacological effects, particularly in the treatment of anxiety and insomnia. Here are some intriguing aspects of this compound:

  • Structural Complexity: The complex structure of this compound incorporates a pyrido structure fused with a benzodiazepine moiety, contributing to its unique properties and potential biological activities.
  • Targeted Action: Compounds like this one are often designed to interact selectively with specific neurotransmitter receptors. They may influence the GABAA receptor, which plays a critical role in the central nervous system's inhibitory processes.
  • Potential Therapeutic Uses: Research indicates that derivatives of this compound class could serve not only as anxiolytics but also exhibit anti-convulsant and muscle-relaxant properties, broadening their application in clinical settings.
  • Innovative Design: The incorporation of a piperazinyl group is a strategic choice in medicinal chemistry aimed at enhancing the compound's binding affinity and overall pharmacokinetic profile.
  • Research and Development: This compound may be a subject of ongoing research to explore its efficacy and safety profiles, particularly in terms of side effects and tolerance in long-term use.

As noted by researchers in the field: "The design and synthesis of novel benzodiazepines promise to reveal significant advancements in our understanding of neuropharmacology." This statement highlights the importance of innovative chemical modifications in the ongoing quest for better therapeutic agents.

In conclusion, the exploration of compounds like 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one not only enriches our chemical repertoire but also fuels future discoveries in the world of medicinal chemistry.

Synonyms
pirenzepine
28797-61-7
Pirenzepin
Gastrozepin
Pirenzepina
Pirenzepinum
Pirenzepinum [INN-Latin]
Pirenzepina [INN-Spanish]
Pirenzepine [INN:BAN]
11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
EINECS 249-228-4
Pirenzepine (INN)
BRN 0628987
ACI-91
CHEBI:8247
11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one
11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
DTXSID7023487
UNII-3G0285N20N
Gastrozepin (TN)
PIRENZEPINE [MI]
PIRENZEPINE [INN]
3G0285N20N
PIRENZEPINE [VANDF]
CHEMBL9967
PIRENZEPINE [WHO-DD]
5,11-Dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one
6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-
DTXCID303487
Pyrenzepine
NCGC00015836-08
Pirenzepinum (INN-Latin)
Pirenzepina (INN-Spanish)
5,11-Dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-
MLS000069702
2-[2-(4-methylpiperazin-1-yl)acetyl]-2,4,9-triazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]- (8CI,9CI)
CAS-28797-61-7
L-S 519
SMR000058502
LS-519
Gastri p
11-(2-(4-methylpiperazin-1-yl)acetyl)-5H-pyrido(2,3-b)(1,4)benzodiazepin-6-one
11-((4-methylpiperazin-1-yl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one
2-(2-(4-methylpiperazin-1-yl)acetyl)-2,4,9-triazatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3,5,7,12,14-hexaen-10-one
PirenzepineDihydrochlorideMonohydrate
Spectrum_001378
Tocris-1071
starbld0016668
Prestwick0_000129
Prestwick1_000129
Prestwick2_000129
Prestwick3_000129
Spectrum2_001417
Spectrum3_001453
Spectrum4_000437
Spectrum5_001344
Lopac-P-7412
Pirenzepine (USAN/INN)
PIRENZEPINE [USAN]
Lopac0_000962
SCHEMBL41705
BSPBio_000178
BSPBio_002945
GTPL328
KBioGR_000794
KBioSS_001858
DivK1c_000127
SPBio_001494
SPBio_002117
BPBio1_000196
cid_185248
BDBM39341
KBio1_000127
KBio2_001858
KBio2_004426
KBio2_006994
KBio3_002445
A02BX03
WST-057
NINDS_000127
HMS2089K21
HMS3742E07
HMS3742G13
BCP12188
Tox21_110239
HY-17037A
PDSP1_000965
PDSP2_000949
AKOS015969751
Tox21_110239_1
CCG-205042
DB00670
SDCCGSBI-0050935.P004
IDI1_000127
NCGC00015836-01
NCGC00015836-02
NCGC00015836-03
NCGC00015836-04
NCGC00015836-05
NCGC00015836-06
NCGC00015836-07
NCGC00015836-09
NCGC00015836-10
NCGC00015836-12
NCGC00015836-19
NCGC00024297-02
NCGC00024297-04
NCGC00024297-05
SBI-0050935.P003
CAS-29868-97-1
AB00053603
CS-0013749
NS00006691
C07508
D08389
AB00053603-08
AB00053603_09
L000485
Q419550
BRD-K89375097-300-05-4
BRD-K89375097-300-06-2
BRD-K89375097-300-08-8
11-[2-(4-methylpiperazino)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
11-(2-(4-Methylpiperazin-1-yl)acetyl)-5,11-dihydro-6H-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one
11-[(4-Methyl-1-piperazinyl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one #
11-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
11-[2-(4-Methyl-piperazin-1-yl)-acetyl]-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one
11-[2-(4-methylpiperazin-1-yl)-acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
11-[2-(4-methylpiperazin-1-yl)ethanoyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride
249-228-4
5,11-Dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-; 6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]- (8CI,9CI); 5,11-Dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-6H-pyr